Upgrade to SI Premium - Free Trial

Piper Jaffray Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral

March 13, 2019 2:36 AM
Piper Jaffray analyst David Amsellem downgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Downgrades

Next Articles